Smooth muscle cell proliferation index correlates with 111In- labeled antibody Z2D3 uptake in a transplant vasculopathy swine model

Journal of Nuclear Medicine

Volumn 46, Issue 3, 2005, Pages 514-519

  Jimenez, Javier ^a,c   Donahay, Tammy ^a   Schofield, Lorraine ^a   Khaw, Ban An ^b   Johnson, Lynne L ^a  

^a BROWN UNIVERSITY   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Monoclonal antibodies; Swine; Transplant vasculopathy

Indexed keywords

BROXURIDINE; INDIUM 111; MONOCLONAL ANTIBODY; TRACER; DIAGNOSTIC AGENT; INDIUM; RADIOPHARMACEUTICAL AGENT;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY TRANSPLANTATION; ARTICLE; AUTORADIOGRAPHY; CAROTID ARTERY; CELL PROLIFERATION; DRUG UPTAKE; IMMUNOHISTOLOGY; IN VIVO STUDY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR PATENCY; ANIMAL; CORONARY ARTERY DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGY; METABOLISM; SCINTISCANNING; STATISTICS; SWINE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL PROLIFERATION; CORONARY DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; INDIUM RADIOISOTOPES; MUSCLE, SMOOTH, VASCULAR; RADIOPHARMACEUTICALS; STATISTICS; SWINE;

EID: 17844401747     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kaye MP. The Registry of the International Society for Heart and Lung Transplantation: tenth official report-1993. J Heart Lung Transplant. 1993;12:541-548.
2. Pucci AM, Forbes RD, Billingham ME. Pathologic features in long-term cardiac allografts. J Heart Transplant. 1990;9:339-345.
3. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant. 1989;8:349-359.
4. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant. 1992;11(suppl):S38-S44.
5. Smart FW, Ballantyne CM, Cocanougher B, et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol. 1991;67:243-247.
6. Carlsen J, Toft JC, Mortensen SA, Arendrop H, Aldersvile J, Hesse B. Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients. J Heart Lung Transplant. 2000;19:873-878.
7. Akosah KO, Moharty PK, Funai JT, et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant. 1994;13:1024-1038.
8. Derumeaux G, Redonnet M, Mouton-Schleifer D, et al. Dobutamine stress echocardiography in orthotopic heart transplant recipients. VACOMED Research Group. J Am Coll Cardiol. 1995;25:1665-1672.
9. Yeung AC, Davis SF, Hauptman PJ, et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant. 1995;14(suppl):S215-S220.
10. Smith-Jones PM, Vallabhajosula S, Navarro V, Bastidas D, Goldsmith SJ, Bander NH. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. J Nucl Med. 2003;44:610-617.
11. 99mTc- Labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma. Nucl Med. 2001;42:1519-1527.
12. 99mtechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen. Clin Cancer Res. 2000;6:4921-4931.
13. Griffiths GL, Goldenberg DM, Roesch F, Hansen HJ. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab′ fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m. Clin Cancer Res. 1999;5(suppl):3001S- 3003S.
14. Buchsbaum DJ, Lawrence TS. New trends in the use of radioimmunoconjugates for the therapy of cancer. Targeted Diagn Ther. 1990;3:215-255.
15. Narula J, Petrov A, Blanchi C, et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab′)2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. Circulation. 1995;92:474-484.
16. Ditlow CC, Chen FW, Calenoff E, inventors; Charles Ventures, assignee. Atherosclerotic plaque specific antigens, antibodies thereof, and uses thereof. US patent 5 811 248. April 26, 1993.
17. Tixier DB, Czer LS, Fishbein MC, et al. Isolated coronary artery transplantation in pigs: a new model to study transplantation arteriosclerosis and humoral rejection. J Heart Lung Transplant. 1996;15:919-927.
18. Johnson LL, Schofield LM, Verdesca SA, et al. In vivo uptake of radiolabeled antibody to proliferating smooth muscle cells in a swine model of coronary stent restenosis. J Nucl Med. 2000;41:1535-1540.
19. Johnson LL, Schofield LM, Weber DK, Kolodgie F, Virmani R, Khaw BA. Uptake of (111)In-Z2D3 on SPECT imaging in a swine model of coronary stent restenosis correlated with cell proliferation. J Nucl Med. 2004;45:294-299.
20. Katsuragawa M, Fujiwara H, Miyamae M, Sasayama S. Histologic studies in percutaneous transluminal coronary angioplasty for chronic total occlusion: comparison of tapering and abrupt types of occlusion and short and long occluded segments. J Am Coll Cardiol. 1993;21:604-611.
21. Saito T, Kimura K, Kosuge M, et al. Relation between the timing of the last preinfarction angina and microvascular reperfusion in patients with recanalized acute myocardial infarction. Jpn Heart J. 2003;44:845-854.
22. Harrison DC, Calenoff FF, Chen FW, Parmey WW, Khaw BA, Ross L. Plaque-associated immune reactivity as a tool for the diagnosis and treatment of atherosclerosis. Trans Am Clin Climatol Assoc. 1992;103:210-217.
23. Narula J, Petrov A, O'Donnell SM, et al. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo target localization. J Nucl Cardiol. 1996;3:231-241.
24. Jimenez J, Donahay T, Schofield L, Khaw BA, Johnson L. Non-invasive detection of transplant vasculopathy using indium-111 tagged Z2D3 antibody in a swine model [abstract]. J Am Coll Cardiol. 2000;35:237A.
25. Carrio I, Pieri PL, Narula J, et al. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol. 1998;5:551-557.
26. Khaw BA, Klibarov A, O'Donnell SM, et al. Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med. 1991;32:1742-1751.
27. Tonchilin VP, Klibanov AL, Nossiff ND, et al. Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding. Hybridoma. 1987;6:229-240.
28. Narula J, Petrov A, Ditlow C, Pak KY, Chen FW, Khaw BA. Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting. J Nucl Cardiol. 1997;4:226-233.